How many think a BTD will be our first approval? I don’t
How many think a BTD will be our first approval? I don’t believe we will achieve a BTD towards an accelerated approval until we accomplish our complete HIV BLA and receive approval. We need to establish a drug safety in a BLA submission that shows a lot of time and patients safely taking our drug. Until we use our HIV data this can’t and won’t happen any time soon for a BTD. Our possible BTD chances are on phase 2 trials as they should be. It’s a quicker steppingstone to get an accelerated approval. They usually take a long time to trial. So our long data in HIV will be huge going forward.
The real game changer is this unmet need for a Covid drug in Critical Covid. This could garner us a EUA and some day a BLA for Covid-19. So could the Long Haulers if we are first to the checkered flag on LH’ers to capture that flag or be heads above any other drug that receives a LH’ers EAU. Now Nash and Cancer will have to wait until we get our drug safety record established with HIV. This is how important HIV is to us. Once we establish safety then quick trials on many indications can happen and seek quick approvals. Look at Truvada and averaging 7 approvals each year the last few years as a platform drug with many indications. We have a platform drug in Leronlimab and many indications to trial. Just think… if we apply for the BLA submission and a week or two later we get our Padufa date 6 months later because of our fast track status… we will be well on our way to much bigger things. This is a major advantage we have in 7 year old data that shows our safety in 800 or more people for HIV and another over 400 people lately with covid and all trials.
It makes me dream at night of the good times that are so close. Everyone wants to know when and how soon… if we keep our management on point right now and don’t upset the Apple cart.. Then we look forward to stepping into these big shoes in 2022 and that will be a remarkable year. This is when it all happens… how many approvals in the year 2022? 1…2… 4 or 5? I sit back and just dream some more… let’s get that HIV BLA submitted and my dreams and I am sure many others will turn into reality. As long as we get our padufa date. We know we hit our primary end point. Our data is being reviewed by each section of the 5 sections of the BLA we are submitting in our rolling review. As each section gets reviewed and accepted… we must know that we are ever closer to our dreams. I know I am happy with what Dr. Recknor has done for us. Sad that the FDA uncertified lab IncellDX couldn’t do this for us. Or we would of probably had it done already. Another reason to not vote for that 13d group who want to buy that over priced lab.
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...
Continue Reading
Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...
Continue Reading
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...
Continue Reading
A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...
Continue Reading
Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...
Continue Reading
Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...
Continue Reading
A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...
Continue Reading
Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...
Continue Reading
Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...
Continue Reading
Top 5 Most Recently Viewed Articles
JPMorgan Adjusts Expectations for Maruti Suzuki Stock Recently, JPMorgan provided an updated perspective on Maruti Suzuki India Ltd (MSIL:IN), lowering its price target to ?12,160 from the previous ?13,275. The firm decided to keep a Neutral rating on the stock, reflecting its cautious approach amidst changing market dynamics. Financial Performance Highlights This...
Continue Reading
UnionPay Launches Payment Solutions for Apple Services UnionPay cardholders have exciting news! They can now seamlessly utilize their cards to pay for a variety of Apple services. This includes popular platforms such as the App Store, Apple Music, Apple TV, iCloud, and much more across selected regions. Expanding Global Reach In an announcement made recently, UnionPay...
Continue Reading
Atlas West's Innovative Approach to Housing Challenges Recently, the CEO of Atlas West, Daniel Shkolnik, addressed a gathering of nearly 400 industry insiders at the inaugural ADU conference, embracing an engaging discussion surrounding Accessory Dwelling Units (ADUs) and their pivotal role in addressing the housing crisis in urban areas. Key Highlights from the ADU Forum...
Continue Reading
Algebrik AI Partners with Carleton for Lending Innovation Algebrik AI Inc., an innovative player in the financial services technology sector, has recently announced a strategic partnership with Carleton, Inc. This collaboration brings forth a transformative approach to consumer lending, focusing on enhancing accuracy, compliance, and operational efficiency within the loan...
Continue Reading
Overview of Baxter International's Legal Situation Baxter International, Inc. (NYSE: BAX) has recently found itself at the center of a securities class action lawsuit. This lawsuit stems from serious allegations concerning its Novum IQ Large Volume Pump (Novum LVP), a device utilized for administering intravenous fluids that carry vital medications, blood products, and...
Continue Reading